Review





Similar Products

docetaxel dtx  (MedChemExpress)
95
MedChemExpress docetaxel dtx
Docetaxel Dtx, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dtx+%26+chi-ag+nps/Docetaxel/pmc13428109-41-7-12
Average 95 stars, based on 1 article reviews
docetaxel dtx - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
thorlabs coolflow dtx coolant  (Thorlabs)
86
Thorlabs thorlabs coolflow dtx coolant
Thorlabs Coolflow Dtx Coolant, supplied by Thorlabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dtx+%26+chi-ag+nps/coolant+coolflow+dtx+thorlabs/10__1093_slash_rasti_slash_rzag039-90-0-0
Average 86 stars, based on 1 article reviews
thorlabs coolflow dtx coolant - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
dtx  (MedChemExpress)
97
MedChemExpress dtx
Docetaxel triggers cuproptosis in breast cancer. (A) Western blotting method analyzing the expression of cuproptosis regulator FDX1 under varying concentrations of <t>DTX</t> with or without 1 <t>µM</t> <t>CuCl</t> 2 ( n = 3). (B) Western blotting method analyzing the expression of FDX1 under varying concentrations of DTX with or without 15 µM TTM ( n = 3). (C) IHC method analyzing the expression of FDX1 protein in clinical samples from breast cancer patients before and after DTX-based neoadjuvant chemotherapy ( n = 10). Scale bar: 200 μm. (D) AC008406.3 expression was measured by ISH experiments, and patients were stratified into high- and low-expression groups to compare DTX chemotherapy response rates ( n = 44). Scale bar: 200 μm. (E) ROC curve showing the predictive performance of AC008406.3 expression for chemotherapy response. (F) Determining the impact of AC008406.3 knockdown on the cytotoxic effects of DTX in breast cancer cells ( n = 4). * p < 0.05, ** p < 0.01, and *** p < 0.001.
Dtx, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dtx+%26+chi-ag+nps/Docetaxel/pmc13215318-147-47-48
Average 97 stars, based on 1 article reviews
dtx - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
hect e3 ligase on deltex dtx  (Deltex Medical)
86
Deltex Medical hect e3 ligase on deltex dtx
Docetaxel triggers cuproptosis in breast cancer. (A) Western blotting method analyzing the expression of cuproptosis regulator FDX1 under varying concentrations of <t>DTX</t> with or without 1 <t>µM</t> <t>CuCl</t> 2 ( n = 3). (B) Western blotting method analyzing the expression of FDX1 under varying concentrations of DTX with or without 15 µM TTM ( n = 3). (C) IHC method analyzing the expression of FDX1 protein in clinical samples from breast cancer patients before and after DTX-based neoadjuvant chemotherapy ( n = 10). Scale bar: 200 μm. (D) AC008406.3 expression was measured by ISH experiments, and patients were stratified into high- and low-expression groups to compare DTX chemotherapy response rates ( n = 44). Scale bar: 200 μm. (E) ROC curve showing the predictive performance of AC008406.3 expression for chemotherapy response. (F) Determining the impact of AC008406.3 knockdown on the cytotoxic effects of DTX in breast cancer cells ( n = 4). * p < 0.05, ** p < 0.01, and *** p < 0.001.
Hect E3 Ligase On Deltex Dtx, supplied by Deltex Medical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dtx+%26+chi-ag+nps/dtx3l+e3+ligase+ubiquitin/pmc13137688-200-25-29
Average 86 stars, based on 1 article reviews
hect e3 ligase on deltex dtx - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
deltex dtx  (Deltex Medical)
86
Deltex Medical deltex dtx
Docetaxel triggers cuproptosis in breast cancer. (A) Western blotting method analyzing the expression of cuproptosis regulator FDX1 under varying concentrations of <t>DTX</t> with or without 1 <t>µM</t> <t>CuCl</t> 2 ( n = 3). (B) Western blotting method analyzing the expression of FDX1 under varying concentrations of DTX with or without 15 µM TTM ( n = 3). (C) IHC method analyzing the expression of FDX1 protein in clinical samples from breast cancer patients before and after DTX-based neoadjuvant chemotherapy ( n = 10). Scale bar: 200 μm. (D) AC008406.3 expression was measured by ISH experiments, and patients were stratified into high- and low-expression groups to compare DTX chemotherapy response rates ( n = 44). Scale bar: 200 μm. (E) ROC curve showing the predictive performance of AC008406.3 expression for chemotherapy response. (F) Determining the impact of AC008406.3 knockdown on the cytotoxic effects of DTX in breast cancer cells ( n = 4). * p < 0.05, ** p < 0.01, and *** p < 0.001.
Deltex Dtx, supplied by Deltex Medical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dtx+%26+chi-ag+nps/dtx3l+e3+ligase+ubiquitin/pmc13150011-31-5-5
Average 86 stars, based on 1 article reviews
deltex dtx - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
dtx pro electronic drum set 16  (Yamaha Corporation)
86
Yamaha Corporation dtx pro electronic drum set 16
Docetaxel triggers cuproptosis in breast cancer. (A) Western blotting method analyzing the expression of cuproptosis regulator FDX1 under varying concentrations of <t>DTX</t> with or without 1 <t>µM</t> <t>CuCl</t> 2 ( n = 3). (B) Western blotting method analyzing the expression of FDX1 under varying concentrations of DTX with or without 15 µM TTM ( n = 3). (C) IHC method analyzing the expression of FDX1 protein in clinical samples from breast cancer patients before and after DTX-based neoadjuvant chemotherapy ( n = 10). Scale bar: 200 μm. (D) AC008406.3 expression was measured by ISH experiments, and patients were stratified into high- and low-expression groups to compare DTX chemotherapy response rates ( n = 44). Scale bar: 200 μm. (E) ROC curve showing the predictive performance of AC008406.3 expression for chemotherapy response. (F) Determining the impact of AC008406.3 knockdown on the cytotoxic effects of DTX in breast cancer cells ( n = 4). * p < 0.05, ** p < 0.01, and *** p < 0.001.
Dtx Pro Electronic Drum Set 16, supplied by Yamaha Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dtx+%26+chi-ag+nps/drum+dtxplorer+electronic+kit/10__18494_slash_sam6119-117-2-1
Average 86 stars, based on 1 article reviews
dtx pro electronic drum set 16 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
dtx irradiator  (Philips Healthcare)
86
Philips Healthcare dtx irradiator
Docetaxel triggers cuproptosis in breast cancer. (A) Western blotting method analyzing the expression of cuproptosis regulator FDX1 under varying concentrations of <t>DTX</t> with or without 1 <t>µM</t> <t>CuCl</t> 2 ( n = 3). (B) Western blotting method analyzing the expression of FDX1 under varying concentrations of DTX with or without 15 µM TTM ( n = 3). (C) IHC method analyzing the expression of FDX1 protein in clinical samples from breast cancer patients before and after DTX-based neoadjuvant chemotherapy ( n = 10). Scale bar: 200 μm. (D) AC008406.3 expression was measured by ISH experiments, and patients were stratified into high- and low-expression groups to compare DTX chemotherapy response rates ( n = 44). Scale bar: 200 μm. (E) ROC curve showing the predictive performance of AC008406.3 expression for chemotherapy response. (F) Determining the impact of AC008406.3 knockdown on the cytotoxic effects of DTX in breast cancer cells ( n = 4). * p < 0.05, ** p < 0.01, and *** p < 0.001.
Dtx Irradiator, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dtx+%26+chi-ag+nps/dtx+irradiator/10__1007_slash_s10853___026___12386___8-67-6-11
Average 86 stars, based on 1 article reviews
dtx irradiator - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
dtx  (Sanofi)
86
Sanofi dtx
Docetaxel triggers cuproptosis in breast cancer. (A) Western blotting method analyzing the expression of cuproptosis regulator FDX1 under varying concentrations of <t>DTX</t> with or without 1 <t>µM</t> <t>CuCl</t> 2 ( n = 3). (B) Western blotting method analyzing the expression of FDX1 under varying concentrations of DTX with or without 15 µM TTM ( n = 3). (C) IHC method analyzing the expression of FDX1 protein in clinical samples from breast cancer patients before and after DTX-based neoadjuvant chemotherapy ( n = 10). Scale bar: 200 μm. (D) AC008406.3 expression was measured by ISH experiments, and patients were stratified into high- and low-expression groups to compare DTX chemotherapy response rates ( n = 44). Scale bar: 200 μm. (E) ROC curve showing the predictive performance of AC008406.3 expression for chemotherapy response. (F) Determining the impact of AC008406.3 knockdown on the cytotoxic effects of DTX in breast cancer cells ( n = 4). * p < 0.05, ** p < 0.01, and *** p < 0.001.
Dtx, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dtx+%26+chi-ag+nps/dtx/pm41787224-249-14-8
Average 86 stars, based on 1 article reviews
dtx - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Docetaxel triggers cuproptosis in breast cancer. (A) Western blotting method analyzing the expression of cuproptosis regulator FDX1 under varying concentrations of DTX with or without 1 µM CuCl 2 ( n = 3). (B) Western blotting method analyzing the expression of FDX1 under varying concentrations of DTX with or without 15 µM TTM ( n = 3). (C) IHC method analyzing the expression of FDX1 protein in clinical samples from breast cancer patients before and after DTX-based neoadjuvant chemotherapy ( n = 10). Scale bar: 200 μm. (D) AC008406.3 expression was measured by ISH experiments, and patients were stratified into high- and low-expression groups to compare DTX chemotherapy response rates ( n = 44). Scale bar: 200 μm. (E) ROC curve showing the predictive performance of AC008406.3 expression for chemotherapy response. (F) Determining the impact of AC008406.3 knockdown on the cytotoxic effects of DTX in breast cancer cells ( n = 4). * p < 0.05, ** p < 0.01, and *** p < 0.001.

Journal: Cancer Biology & Therapy

Article Title: Suppression of LncRNA AC008406.3 sensitizes breast cancer cells to docetaxel via triggering cuproptosis

doi: 10.1080/15384047.2026.2676474

Figure Lengend Snippet: Docetaxel triggers cuproptosis in breast cancer. (A) Western blotting method analyzing the expression of cuproptosis regulator FDX1 under varying concentrations of DTX with or without 1 µM CuCl 2 ( n = 3). (B) Western blotting method analyzing the expression of FDX1 under varying concentrations of DTX with or without 15 µM TTM ( n = 3). (C) IHC method analyzing the expression of FDX1 protein in clinical samples from breast cancer patients before and after DTX-based neoadjuvant chemotherapy ( n = 10). Scale bar: 200 μm. (D) AC008406.3 expression was measured by ISH experiments, and patients were stratified into high- and low-expression groups to compare DTX chemotherapy response rates ( n = 44). Scale bar: 200 μm. (E) ROC curve showing the predictive performance of AC008406.3 expression for chemotherapy response. (F) Determining the impact of AC008406.3 knockdown on the cytotoxic effects of DTX in breast cancer cells ( n = 4). * p < 0.05, ** p < 0.01, and *** p < 0.001.

Article Snippet: The reagents’ information is listed as follows: Elesclomol (ES; MedChem Express HY-12040), ML162 (MedChem Express HY-100002), Tetrathiomolybdate (TTM; Sigma-Aldrich 323446), Ferrostatin-1 (Fer-1; MedChem Express HY-100579), N -acetylcysteine (NAC; MedChem Express HY-B0215), Necrostatin-1 (Nec-1; MedChem Express HY-15760), Z-VAD-FMK (ZVF; MedChem Express HY-16658B), Dimethyl sulfoxide (DMSO; MedChem Express HY-Y0320), DTX (MedChem Express HY-B0011), Anhydrous copper (II) chloride (CuCl 2 ; Macklin 7447-39-4).

Techniques: Western Blot, Expressing, Knockdown